The U.S. Food and Drug Administration’s advisory panel has voted to allow emergency use authorization of Pfizer’s shot in kids ages 5 to 11.
The U.S. Food and Drug Administration’s advisory panel has voted to allow emergency use authorization of Pfizer’s shot in kids ages 5 to 11.